Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Case-Control Studies [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
MAFD6 [NCBI] 0.00369453
apnea, obstructive sleep [NCBI] 0.00298753
CHDS8 [NCBI] 0.00199675
lymphoma, non-hodgkin, familial [NCBI] 0.00143277
alzheimer disease 6 [NCBI] 0.00132604
SLE [NCBI] 0.00129318
behcet syndrome [NCBI] 0.0010743
AD [NCBI] 0.000973211
CRCS2 [NCBI] 0.000971031
SCZD7 [NCBI] 0.000936532
CD [NCBI] 0.000831712
restless legs syndrome, susceptibility to, 6 [NCBI] 0.0008119
CELIAC6 [NCBI] 0.0008119
sjogren syndrome [NCBI] 0.000811309
IBD5 [NCBI] 0.000811309
RA [NCBI] 0.000716972
PEE1 [NCBI] 0.000675766
wegener granulomatosis [NCBI] 0.000664788
HDLCQ1 [NCBI] 0.000664788
opticocochleodentate degeneration [NCBI] 0.000664788
PD [NCBI] 0.000619139
APOE [NCBI] 0.000595866
ARMD4 [NCBI] 0.000580134
GPS [NCBI] 0.000564613
gastroesophageal reflux [NCBI] 0.000505607
pulmonary disease, chronic obstructive [NCBI] 0.000505607
alzheimer disease 8 [NCBI] 0.000505607
scleroderma, familial progressive [NCBI] 0.000456389
PCOS1 [NCBI] 0.000435323
VDR [NCBI] 0.000429017
hashimoto thyroiditis [NCBI] 0.000412189
DFNB13 [NCBI] 0.000405577
HHF7 [NCBI] 0.000405577
MAFD4 [NCBI] 0.000405577
alzheimer disease 7 [NCBI] 0.000405577
HFM [NCBI] 0.000398761
IDDM [NCBI] 0.000382774
CRC [NCBI] 0.000381568
COMT [NCBI] 0.000375789
MAFD1 [NCBI] 0.000343306
VEGF [NCBI] 0.000337018
EGF [NCBI] 0.000329722
IS1 [NCBI] 0.00031486
SHBG [NCBI] 0.00031273
myasthenia gravis with thymus hyperplasia [NCBI] 0.000311479
PSORS5 [NCBI] 0.000311479
AUTS7 [NCBI] 0.000311479
asthma-related traits, susceptibility to, 6 [NCBI] 0.000311479
osteogenesis imperfecta, type vi [NCBI] 0.000311479
GLC1M [NCBI] 0.000311479
MBL2 [NCBI] 0.000304574
TNFRSF11B [NCBI] 0.000257276
peyronie disease [NCBI] 0.000252478
opioid dependence, susceptibility to, 1 [NCBI] 0.000252478
psoriasis susceptibility 8 [NCBI] 0.000252478
SCZD5 [NCBI] 0.000252478
ulcerative colitis, susceptibility to [NCBI] 0.000247953
FTD [NCBI] 0.000246034
OFC1 [NCBI] 0.000242393
CFH [NCBI] 0.000235842
IBD1 [NCBI] 0.000225687
RNASE3 [NCBI] 0.000223487
AD14 [NCBI] 0.000210147
IBD3 [NCBI] 0.000210147
AD13 [NCBI] 0.000210147
migraine with or without aura, susceptibility to, 5 [NCBI] 0.000210147
SCZD3 [NCBI] 0.000208998
CPI [NCBI] 0.000208209
NGFB [NCBI] 0.000204577
VRNI [NCBI] 0.000196043
ACE [NCBI] 0.000195134
TCF7L2 [NCBI] 0.000190753
FA [NCBI] 0.000184977
TFPI [NCBI] 0.000178728
stature as a quantitative trait [NCBI] 0.000177634
HCFP1 [NCBI] 0.000177634
neutrophilic dermatosis, acute febrile [NCBI] 0.000177634
ATOD6 [NCBI] 0.000177634
NIDDM2 [NCBI] 0.000177634
LTA [NCBI] 0.000172897
malaria, susceptibility to [NCBI] 0.00016553
mycobacterium tuberculosis, susceptibility to [NCBI] 0.000156098
MTR [NCBI] 0.000155961
AITD3 [NCBI] 0.000154988
PHP [NCBI] 0.000151608
cluster headache, familial [NCBI] 0.000151608
deafness, congenital, and onychodystrophy, recessive form [NCBI] 0.000151608
pulmonary alveolar proteinosis, acquired [NCBI] 0.000151608
PSORS4 [NCBI] 0.000151608
MYMY1 [NCBI] 0.000151608
MENOQ1 [NCBI] 0.000151608
ACHE [NCBI] 0.000146787
FSHMD1A [NCBI] 0.00014353
ALD [NCBI] 0.000138409
MTHFR [NCBI] 0.000138193
NAT1 [NCBI] 0.000137444
migraine with or without aura, susceptibility to, 1 [NCBI] 0.000134813
polycystic kidneys [NCBI] 0.000133881
asthma, susceptibility to [NCBI] 0.000133242
severe cutaneous adverse reaction, susceptibility to [NCBI] 0.000132781
acne, adult [NCBI] 0.000131495
ARMD9 [NCBI] 0.000131495
AUTS9 [NCBI] 0.000130195
myoclonic epilepsy, juvenile, 3 [NCBI] 0.000130195
prostate cancer, hereditary, 8 [NCBI] 0.000130195
restless legs syndrome, susceptibility to, 1 [NCBI] 0.000125184
prostate cancer [NCBI] 0.000122845
CDKAL1 [NCBI] 0.000122292
obesity [NCBI] 0.000120632
APC [NCBI] 0.000120553
IBD2 [NCBI] 0.000112229
constricting bands, congenital [NCBI] 0.000112229
SCZD6 [NCBI] 0.000112229
NPY [NCBI] 0.000111233
CF [NCBI] 0.000108026
aplastic anemia [NCBI] 0.000104547
TS [NCBI] 0.000103657
TH [NCBI] 0.000103219
RP [NCBI] 0.000101947
EPHX1 [NCBI] 0.000100776
SLC30A8 [NCBI] 9.75731e-05
SUMO4 [NCBI] 9.75731e-05
IL23R [NCBI] 9.75731e-05
PARK3 [NCBI] 9.69402e-05
HPCX [NCBI] 9.69402e-05
IDD [NCBI] 9.50525e-05
PPROM [NCBI] 9.40048e-05
BL [NCBI] 9.24771e-05
SOD2 [NCBI] 9.19293e-05
IL10 [NCBI] 9.10743e-05
osteoarthritis [NCBI] 8.9871e-05
CHAT [NCBI] 8.93539e-05
GIST [NCBI] 8.91395e-05
NRG1 [NCBI] 8.85166e-05
NOS3 [NCBI] 8.58204e-05
PTK2 [NCBI] 8.43537e-05
OTSC1 [NCBI] 8.37897e-05
dandy-walker-like malformation with atrioventricular septal defect [NCBI] 8.37897e-05
CAT [NCBI] 8.37571e-05
VIP [NCBI] 8.33969e-05
EGFR [NCBI] 8.32045e-05
GFAP [NCBI] 8.31495e-05
g30 gene [NCBI] 8.30435e-05
SHEP2 [NCBI] 8.27226e-05
PAI1 [NCBI] 8.22792e-05
ELAC2 [NCBI] 8.21706e-05
MDD [NCBI] 8.1417e-05
CCND1 [NCBI] 7.91532e-05
leber optic atrophy [NCBI] 7.85534e-05
NOD2 [NCBI] 7.85321e-05
CPB2 [NCBI] 7.82447e-05
cortisone reductase deficiency [NCBI] 7.74808e-05
leprosy, susceptibility to, 2 [NCBI] 7.74808e-05
bilirubin, elevated concentrations of, in serum [NCBI] 7.74808e-05
MPO [NCBI] 7.73575e-05
graves disease [NCBI] 7.71389e-05
DGS [NCBI] 7.52775e-05
stroke, ischemic [NCBI] 7.47723e-05
loc387715 gene [NCBI] 7.44903e-05
BWS [NCBI] 7.42711e-05
SCZD [NCBI] 7.3991e-05
AVP [NCBI] 7.25513e-05
ETL2 [NCBI] 7.23873e-05
SDS [NCBI] 7.19544e-05
WAS [NCBI] 7.15368e-05
F3 [NCBI] 7.13513e-05
breast cancer [NCBI] 7.03777e-05
FTO [NCBI] 6.96853e-05
IGF2BP2 [NCBI] 6.96853e-05
sarcoidosis [NCBI] 6.89582e-05
MODY [NCBI] 6.83502e-05
DFSP [NCBI] 6.81317e-05
PJS [NCBI] 6.74865e-05
IDDM12 [NCBI] 6.63777e-05
BULN2 [NCBI] 6.57439e-05
BPH [NCBI] 6.57439e-05
MODY7 [NCBI] 6.57439e-05
LCA12 [NCBI] 6.57439e-05
diamond-blackfan anemia 3 [NCBI] 6.57439e-05
leukocyte nuclear appendages, hereditary prevalence of [NCBI] 6.57439e-05
cleft lip, congenital healed [NCBI] 6.57439e-05
syncope, familial neurocardiogenic [NCBI] 6.57439e-05
SCDO2 [NCBI] 6.57439e-05
appendicitis, proneness to [NCBI] 6.57439e-05
hyperlexia [NCBI] 6.57439e-05
angiokeratoma corporis diffusum with arteriovenous fistulas [NCBI] 6.57439e-05
HYT8 [NCBI] 6.57439e-05
PSNP1 [NCBI] 6.46742e-05
HTR2A [NCBI] 6.37291e-05
scott syndrome [NCBI] 6.24405e-05
FEB1 [NCBI] 6.24405e-05
ST8 [NCBI] 6.24405e-05
nonarteritic anterior ischemic optic neuropathy, susceptibility to [NCBI] 5.80483e-05
amyloidosis vi [NCBI] 5.76809e-05
TNF [NCBI] 5.69326e-05
PPR [NCBI] 5.64233e-05
NPPA [NCBI] 5.62816e-05
ENPP1 [NCBI] 5.52434e-05
PG [NCBI] 5.50722e-05
PWS [NCBI] 5.32386e-05
IRF5 [NCBI] 5.31744e-05
SMAX1 [NCBI] 5.28839e-05
DHFR [NCBI] 5.21587e-05
autism [NCBI] 5.14553e-05
ARMD7 [NCBI] 5.14264e-05
CAPN10 [NCBI] 5.10899e-05
HHEX [NCBI] 5.09764e-05
FRAP1 [NCBI] 5.09157e-05
PROCR [NCBI] 5.05047e-05
HBB [NCBI] 4.99051e-05
CDSN [NCBI] 4.98299e-05
PMD [NCBI] 4.97777e-05
AR [NCBI] 4.94271e-05
PON1 [NCBI] 4.91194e-05
CLEC16A [NCBI] 4.89229e-05
g72 gene [NCBI] 4.89229e-05
PLA2G7 [NCBI] 4.71596e-05
homocysteinemia [NCBI] 4.69321e-05
CTLA4 [NCBI] 4.62217e-05
PAND1 [NCBI] 4.60642e-05
alopecia areata 1 [NCBI] 4.60642e-05
PDCD1 [NCBI] 4.54812e-05
DTNBP1 [NCBI] 4.54812e-05
ALOX5AP [NCBI] 4.54812e-05
ADIPOQ [NCBI] 4.54582e-05
MS [NCBI] 4.4231e-05
PRL [NCBI] 4.42044e-05
NIDDM [NCBI] 4.38328e-05
BCNS [NCBI] 4.30472e-05
RNASEL [NCBI] 4.24808e-05
LAM [NCBI] 4.2443e-05
SLC22A4 [NCBI] 4.23751e-05
SRS [NCBI] 4.19756e-05
POMC [NCBI] 4.16665e-05
PCNA [NCBI] 4.15449e-05
tobacco addiction, susceptibility to [NCBI] 4.13507e-05
NIDDM1 [NCBI] 4.13507e-05
KTCN1 [NCBI] 4.09094e-05
CCK [NCBI] 4.02329e-05
SCGB3A2 [NCBI] 3.98787e-05
MTRR [NCBI] 3.98787e-05
AGER [NCBI] 3.97858e-05
IGAD1 [NCBI] 3.93174e-05
ARMD3 [NCBI] 3.87371e-05
SIDDT [NCBI] 3.87371e-05
IPD1 [NCBI] 3.87371e-05
myelofibrosis, familial [NCBI] 3.87371e-05
STQTL9 [NCBI] 3.87371e-05
cardiomyopathy, dilated, with quadriceps myopathy [NCBI] 3.87371e-05
gambling, pathologic [NCBI] 3.87371e-05
SCDO3 [NCBI] 3.87371e-05
myocardial infarction, susceptibility to, 1 [NCBI] 3.87371e-05
ETM1 [NCBI] 3.85054e-05
ELOVL4 [NCBI] 3.77162e-05
FCRL3 [NCBI] 3.76501e-05
GNRH1 [NCBI] 3.76431e-05
hla-d histocompatibility type [NCBI] 3.74075e-05
fragile x mental retardation syndrome [NCBI] 3.73854e-05
alzheimer disease, susceptibility to, mitochondrial [NCBI] 3.7376e-05
IDE [NCBI] 3.69418e-05
DRD2 [NCBI] 3.65513e-05
PSEN2 [NCBI] 3.65513e-05
aortic aneurysm, abdominal [NCBI] 3.62606e-05
CHEK2 [NCBI] 3.6069e-05
ACH [NCBI] 3.58924e-05
MC1R [NCBI] 3.54852e-05
factor v deficiency [NCBI] 3.54362e-05
SMS [NCBI] 3.53062e-05
PXE [NCBI] 3.47953e-05
CDKN2B [NCBI] 3.41089e-05
OCD1 [NCBI] 3.39054e-05
CRP [NCBI] 3.35834e-05
HLA-DRB1 [NCBI] 3.35834e-05
MMP3 [NCBI] 3.34431e-05
MAOA [NCBI] 3.34285e-05
cayler cardiofacial syndrome [NCBI] 3.33703e-05
WBS [NCBI] 3.29892e-05
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity [NCBI] 3.28978e-05
aHUS [NCBI] 3.28978e-05
PLEKHA1 [NCBI] 3.26138e-05
BTBD9 [NCBI] 3.26138e-05
CFHR3 [NCBI] 3.26138e-05
FRDA [NCBI] 3.24013e-05
AIS [NCBI] 3.23034e-05
LBP [NCBI] 3.19042e-05
GSTM1 [NCBI] 3.18711e-05
hypercholesterolemia, autosomal dominant [NCBI] 3.18258e-05
AT [NCBI] 3.09039e-05
osteoporosis, juvenile [NCBI] 3.08417e-05
SHH [NCBI] 3.07936e-05
KLK3 [NCBI] 3.06059e-05
TLR4 [NCBI] 3.05508e-05
GTS [NCBI] 3.03455e-05
TNFRSF10A [NCBI] 3.03008e-05
MBP [NCBI] 2.99393e-05
CP [NCBI] 2.978e-05
ARMD1 [NCBI] 2.92085e-05
PTPN2 [NCBI] 2.91873e-05
saitohin [NCBI] 2.91873e-05
PACRG [NCBI] 2.91873e-05
MTX1 [NCBI] 2.91873e-05
ADAM33 [NCBI] 2.91873e-05
NPR2 [NCBI] 2.91873e-05
ATMDS [NCBI] 2.90211e-05
pulmonary hypertension, familial persistent, of the newborn [NCBI] 2.90211e-05
sertoli cell-only syndrome [NCBI] 2.90211e-05
CELIAC3 [NCBI] 2.90211e-05
dermatitis herpetiformis, familial [NCBI] 2.90211e-05
HJMD [NCBI] 2.90211e-05
leprosy, susceptibility to, 4 [NCBI] 2.90211e-05
diabetic nephropathy, susceptibility to [NCBI] 2.90211e-05
IL6 [NCBI] 2.88707e-05
KCNJ11 [NCBI] 2.88529e-05
LRRK2 [NCBI] 2.87512e-05
lung cancer [NCBI] 2.85982e-05
IGFALS [NCBI] 2.85887e-05
abdominal obesity-metabolic syndrome [NCBI] 2.81287e-05
MBS [NCBI] 2.81287e-05
IGAN1 [NCBI] 2.81287e-05
proteus syndrome [NCBI] 2.81287e-05
alzheimer disease 2 [NCBI] 2.81133e-05
BMND1 [NCBI] 2.81133e-05
HGF [NCBI] 2.80762e-05
ADA [NCBI] 2.79958e-05
SLC6A4 [NCBI] 2.78628e-05
THBD [NCBI] 2.7616e-05
AGT [NCBI] 2.75233e-05
HLA-B [NCBI] 2.75115e-05
IL8 [NCBI] 2.75115e-05
SLPI [NCBI] 2.72414e-05
MG [NCBI] 2.69611e-05
INSR [NCBI] 2.6722e-05
SH2B3 [NCBI] 2.65844e-05
DLG5 [NCBI] 2.65844e-05
SBDS [NCBI] 2.65844e-05
BRCA1 [NCBI] 2.64519e-05
MYOC [NCBI] 2.63289e-05
A2M [NCBI] 2.61639e-05
F2 [NCBI] 2.57306e-05
DMD [NCBI] 2.57029e-05
MUC1 [NCBI] 2.56955e-05
ICAM1 [NCBI] 2.56713e-05
FFI [NCBI] 2.56272e-05
PTPN22 [NCBI] 2.47447e-05
MMP8 [NCBI] 2.44886e-05
KLF11 [NCBI] 2.44886e-05
TLR10 [NCBI] 2.44886e-05
SLC11A1 [NCBI] 2.44855e-05
CYP4F22 [NCBI] 2.44555e-05
flj10986 [NCBI] 2.44555e-05
C15ORF21 [NCBI] 2.44555e-05
MIAT [NCBI] 2.44555e-05
ORMDL3 [NCBI] 2.44555e-05
GDNF [NCBI] 2.43369e-05
PPARG [NCBI] 2.35726e-05
aneurysm, intracranial berry, 1 [NCBI] 2.35141e-05
ZS [NCBI] 2.34406e-05
mental retardation, x-linked, syndromic, jarid1c-related [NCBI] 2.29805e-05
buruli ulcer, susceptibility to [NCBI] 2.29805e-05
FHCA [NCBI] 2.29805e-05
CELIAC4 [NCBI] 2.29805e-05
CHBL [NCBI] 2.29805e-05
FRAXF [NCBI] 2.29805e-05
allergic rhinitis [NCBI] 2.29805e-05
CORDX3 [NCBI] 2.29805e-05
LI3 [NCBI] 2.29805e-05
orofacial cleft 5 [NCBI] 2.29805e-05
RTT [NCBI] 2.2881e-05
IRGM [NCBI] 2.27379e-05
CCHCR1 [NCBI] 2.27379e-05
HPS [NCBI] 2.27125e-05
CRH [NCBI] 2.23793e-05
CASP8 [NCBI] 2.1638e-05
LTC4S [NCBI] 2.1638e-05
LEP [NCBI] 2.14403e-05
FGF20 [NCBI] 2.12378e-05
CYSLTR1 [NCBI] 2.12378e-05
CFHR1 [NCBI] 2.12378e-05
NOTCH4 [NCBI] 2.12378e-05
PBEF1 [NCBI] 2.12378e-05
LEPR [NCBI] 2.09585e-05
MAG [NCBI] 2.08948e-05
SRD5A2 [NCBI] 2.03126e-05
LRP5 [NCBI] 2.03126e-05
DRD4 [NCBI] 2.01971e-05
gastric cancer [NCBI] 2.00198e-05
hypogonadotropic hypogonadism [NCBI] 1.99889e-05
GSTT1 [NCBI] 1.99281e-05
ERBB3 [NCBI] 1.99281e-05
ASPN [NCBI] 1.99281e-05
HTRA1 [NCBI] 1.99281e-05
CYP2E [NCBI] 1.99281e-05
MJD [NCBI] 1.98014e-05
DYT3 [NCBI] 1.96335e-05
FXTAS [NCBI] 1.96335e-05
HPC1 [NCBI] 1.96335e-05
EDC [NCBI] 1.96335e-05
chiari malformation type i [NCBI] 1.94605e-05
STAT3 [NCBI] 1.93246e-05
danubian endemic familial nephropathy [NCBI] 1.92104e-05
wilson disease [NCBI] 1.91947e-05
ATXN8OS [NCBI] 1.9107e-05
IL4R [NCBI] 1.9107e-05
PARK2 [NCBI] 1.89703e-05
CVS [NCBI] 1.88461e-05
INSIG2 [NCBI] 1.87681e-05
RCD3A [NCBI] 1.86855e-05
IDDM10 [NCBI] 1.86855e-05
thrombophilia due to deficiency of activated protein c cofactor [NCBI] 1.86855e-05
DFNB12 [NCBI] 1.86855e-05
TINU [NCBI] 1.86855e-05
ovarian cancer, epithelial [NCBI] 1.86855e-05
budd-chiari syndrome [NCBI] 1.86855e-05
tropical calcific pancreatitis [NCBI] 1.86855e-05
asthma-related traits, susceptibility to, 5 [NCBI] 1.86855e-05
WRN [NCBI] 1.86772e-05
BLM [NCBI] 1.81628e-05
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 1.81628e-05
CCL22 [NCBI] 1.81057e-05
FABP2 [NCBI] 1.80038e-05
CYP2D6 [NCBI] 1.79139e-05
CFB [NCBI] 1.79139e-05
panencephalitis, subacute sclerosing [NCBI] 1.78517e-05
ADH3 [NCBI] 1.77289e-05
TGFB3 [NCBI] 1.77289e-05
UBQLN1 [NCBI] 1.77289e-05
SLC6A3 [NCBI] 1.76874e-05
CHGA [NCBI] 1.7486e-05
GP1BA [NCBI] 1.7486e-05
NS1 [NCBI] 1.7144e-05
PMCH [NCBI] 1.71217e-05
IL1B [NCBI] 1.69888e-05
RBP4 [NCBI] 1.69888e-05
PRODH [NCBI] 1.69888e-05
KSS [NCBI] 1.6983e-05
SFRP4 [NCBI] 1.67893e-05
CD209 [NCBI] 1.67893e-05
drug metabolism, poor, cyp2d6-related [NCBI] 1.66773e-05
NFKB1 [NCBI] 1.65427e-05
CBAVD [NCBI] 1.64425e-05
AS [NCBI] 1.64321e-05
IL2 [NCBI] 1.63946e-05
HP [NCBI] 1.63217e-05
PDSS2 [NCBI] 1.63062e-05
OR13G1 [NCBI] 1.63062e-05
SETDB2 [NCBI] 1.63062e-05
kiaa1324 [NCBI] 1.63062e-05
mei1, mouse, homolog of [NCBI] 1.63062e-05
ZFAT1 [NCBI] 1.63062e-05
TMPRSS11A [NCBI] 1.63062e-05
SLC12A8 [NCBI] 1.63062e-05
neurotrimin [NCBI] 1.63062e-05
LRCH1 [NCBI] 1.63062e-05
TAS2R50 [NCBI] 1.63062e-05
dendritic cell nuclear protein 1 [NCBI] 1.63062e-05
PGLYRP3 [NCBI] 1.63062e-05
HORMAD1 [NCBI] 1.63062e-05
MEX3C [NCBI] 1.63062e-05
OCLM [NCBI] 1.63062e-05
mesoderm posterior 1 [NCBI] 1.63062e-05
GCET2 [NCBI] 1.63062e-05
PGLYRP4 [NCBI] 1.63062e-05
ENDOGL1 [NCBI] 1.63062e-05
MTNR1B [NCBI] 1.63062e-05
XYLT2 [NCBI] 1.63062e-05
ABCC1 [NCBI] 1.61148e-05
IL12B [NCBI] 1.6051e-05
ESR1 [NCBI] 1.60249e-05
HCRTR2 [NCBI] 1.59331e-05
MTHFD1 [NCBI] 1.59331e-05
EBI3 [NCBI] 1.59331e-05
EIG [NCBI] 1.55264e-05
EVR4 [NCBI] 1.54185e-05
SMDP2 [NCBI] 1.54185e-05
EHBA [NCBI] 1.54185e-05
azoospermia due to perturbations of meiosis [NCBI] 1.54185e-05
osteogenesis imperfecta, type i [NCBI] 1.51484e-05
FOLR1 [NCBI] 1.51481e-05
P2RX7 [NCBI] 1.51481e-05
autonomic control, congenital failure of [NCBI] 1.5041e-05
AMH [NCBI] 1.48254e-05
TNFSF13B [NCBI] 1.47691e-05
SCA2 [NCBI] 1.46588e-05
LPL [NCBI] 1.45448e-05
CYP3A4 [NCBI] 1.3987e-05
FOXP3 [NCBI] 1.38795e-05
PSORS1 [NCBI] 1.37988e-05
ADRB1 [NCBI] 1.37535e-05
ALOX5 [NCBI] 1.37535e-05
GABRB3 [NCBI] 1.37535e-05
PSACH [NCBI] 1.36915e-05
thrombocytopenic purpura, autoimmune [NCBI] 1.36835e-05
MICA [NCBI] 1.36153e-05
OPTN [NCBI] 1.36153e-05
PSEN1 [NCBI] 1.36108e-05
PHF20 [NCBI] 1.32915e-05
PTGES2 [NCBI] 1.32915e-05
PADI3 [NCBI] 1.32915e-05
MMSDH [NCBI] 1.32915e-05
FOLR2 [NCBI] 1.32915e-05
HCLS1 [NCBI] 1.32915e-05
ERDA1 [NCBI] 1.32915e-05
PADI1 [NCBI] 1.32915e-05
PADI2 [NCBI] 1.32915e-05
kiaa1199 [NCBI] 1.32915e-05
USP26 [NCBI] 1.32915e-05
PDE6H [NCBI] 1.32915e-05
HOXB1 [NCBI] 1.32915e-05
GPR78 [NCBI] 1.32915e-05
SCG3 [NCBI] 1.32915e-05
C1ORF36 [NCBI] 1.32915e-05
CYP2C18 [NCBI] 1.32915e-05
TOX3 [NCBI] 1.32915e-05
RPL30 [NCBI] 1.32915e-05
MTTS2 [NCBI] 1.32915e-05
HNMT [NCBI] 1.32557e-05
DSG1 [NCBI] 1.32557e-05
IL7R [NCBI] 1.31296e-05
GJA4 [NCBI] 1.31296e-05
BRCA2 [NCBI] 1.30577e-05
TNFRSF1B [NCBI] 1.29076e-05
LGMD1C [NCBI] 1.28309e-05
hypospadias, autosomal [NCBI] 1.28309e-05
SCA5 [NCBI] 1.28309e-05
IDDM5 [NCBI] 1.28309e-05
CO [NCBI] 1.28309e-05
cataract-microcornea syndrome [NCBI] 1.28309e-05
CSNB1B [NCBI] 1.28309e-05
WT5 [NCBI] 1.28309e-05
thyrotoxic periodic paralysis [NCBI] 1.28309e-05
pemphigus vulgaris, familial [NCBI] 1.28309e-05
VCAM1 [NCBI] 1.25471e-05
ANGPT2 [NCBI] 1.25471e-05
KRT20 [NCBI] 1.25272e-05
ADHD [NCBI] 1.23527e-05
SOD1 [NCBI] 1.22964e-05
FGF7 [NCBI] 1.21806e-05
APP [NCBI] 1.21643e-05
MC4R [NCBI] 1.2133e-05
IAPP [NCBI] 1.20657e-05
NR4A2 [NCBI] 1.20014e-05
MUTYH [NCBI] 1.20014e-05
ADRB3 [NCBI] 1.20014e-05
TNFRSF13B [NCBI] 1.20014e-05
AMACR [NCBI] 1.19266e-05
AHR [NCBI] 1.17132e-05
SPP1 [NCBI] 1.16214e-05
CYP17A1 [NCBI] 1.16192e-05
PHB [NCBI] 1.14889e-05
NCSTN [NCBI] 1.14889e-05
HSD11B1 [NCBI] 1.14889e-05
sudden infant death syndrome [NCBI] 1.14631e-05
ICA1 [NCBI] 1.13683e-05
GFI1B [NCBI] 1.13683e-05
BAAT [NCBI] 1.13683e-05
DNMBP [NCBI] 1.13683e-05
IL1R2 [NCBI] 1.13683e-05
pcna-associated factor, 15-kd [NCBI] 1.13683e-05
SPTBN2 [NCBI] 1.13683e-05
GPR40 [NCBI] 1.13683e-05
FACL5 [NCBI] 1.13683e-05
CHGB [NCBI] 1.13683e-05
XYLT1 [NCBI] 1.13683e-05
APBB2 [NCBI] 1.13683e-05
PRKCH [NCBI] 1.13683e-05
LSP1 [NCBI] 1.13683e-05
RAD9A [NCBI] 1.13683e-05
VIPR2 [NCBI] 1.13683e-05
MYOM2 [NCBI] 1.13683e-05
protein z-dependent protease inhibitor precursor [NCBI] 1.13683e-05
PSMA6 [NCBI] 1.13683e-05
STIP1 [NCBI] 1.13683e-05
BOLL [NCBI] 1.13683e-05
GPR39 [NCBI] 1.13683e-05
PHF11 [NCBI] 1.13683e-05
POU6F2 [NCBI] 1.13683e-05
LGALS13 [NCBI] 1.13683e-05
SRR [NCBI] 1.13683e-05
GAPDHS [NCBI] 1.13683e-05
OSM [NCBI] 1.10116e-05
DRD3 [NCBI] 1.10063e-05
ACPP [NCBI] 1.07721e-05
IFNG [NCBI] 1.07493e-05
OPLL [NCBI] 1.07262e-05
MFS2 [NCBI] 1.07262e-05
colorectal adenomatous polyposis, autosomal recessive [NCBI] 1.07262e-05
prostate cancer/brain cancer susceptibility [NCBI] 1.07262e-05
ear wax, wet/dry [NCBI] 1.07262e-05
ehlers-danlos syndrome, type iii [NCBI] 1.07262e-05
vacterl association with hydrocephalus, x-linked [NCBI] 1.07262e-05
ODG2 [NCBI] 1.07262e-05
JBTS3 [NCBI] 1.07262e-05
AMDM [NCBI] 1.07262e-05
DBH [NCBI] 1.05507e-05
IL1RN [NCBI] 1.05507e-05
SELP [NCBI] 1.05507e-05
HLA-DQB1 [NCBI] 1.05507e-05
MEN2A [NCBI] 1.04437e-05
APRT [NCBI] 1.03216e-05
diabetes mellitus, transient neonatal, 1 [NCBI] 1.01437e-05
AACT [NCBI] 1.01197e-05
ANXA5 [NCBI] 1.01197e-05
BCR [NCBI] 1.00231e-05
HGPS [NCBI] 9.99913e-06
CHH [NCBI] 9.99913e-06
TD1 [NCBI] 9.99913e-06
AHRR [NCBI] 9.96341e-06
GPR44 [NCBI] 9.96341e-06
ZDHHC8 [NCBI] 9.96341e-06
OPTC [NCBI] 9.96341e-06
PLXNA2 [NCBI] 9.96341e-06
LGALS2 [NCBI] 9.96341e-06
ABCC11 [NCBI] 9.96341e-06
NCR3 [NCBI] 9.96341e-06
CHI3L1 [NCBI] 9.96341e-06
CSTA [NCBI] 9.96341e-06
POSTN [NCBI] 9.96341e-06
CYSLTR2 [NCBI] 9.96341e-06
ATG16L1 [NCBI] 9.96341e-06
SNCAIP [NCBI] 9.96341e-06
CYP2R1 [NCBI] 9.96341e-06
MTUS1 [NCBI] 9.96341e-06
SAA4 [NCBI] 9.96341e-06
SRPR [NCBI] 9.96341e-06
FADS1 [NCBI] 9.96341e-06
MX1 [NCBI] 9.96341e-06
ADMR [NCBI] 9.96341e-06
UBE2A [NCBI] 9.96341e-06
TJP2 [NCBI] 9.96341e-06
RPS24 [NCBI] 9.96341e-06
MGLL [NCBI] 9.96341e-06
FUT7 [NCBI] 9.96341e-06
IRAK3 [NCBI] 9.96341e-06
RNASE2 [NCBI] 9.93837e-06
ALPS [NCBI] 9.91635e-06
GJA1 [NCBI] 9.83736e-06
PTHLH [NCBI] 9.68909e-06
LRP1 [NCBI] 9.52574e-06
F13A1 [NCBI] 9.45408e-06
LCAT [NCBI] 9.13523e-06
PLG [NCBI] 8.99119e-06
xx male syndrome [NCBI] 8.98249e-06
polydactyly, postaxial, type a1 [NCBI] 8.98249e-06
ADHR [NCBI] 8.98249e-06
hypoalphalipoproteinemia, primary [NCBI] 8.98249e-06
SBS [NCBI] 8.98249e-06
aspirin resistance [NCBI] 8.98249e-06
HHF6 [NCBI] 8.98249e-06
ELA2 [NCBI] 8.95512e-06
PLTP [NCBI] 8.9139e-06
MAPT [NCBI] 8.90489e-06
MFRP [NCBI] 8.86383e-06
OPCML [NCBI] 8.86383e-06
MESP2 [NCBI] 8.86383e-06
PCDH8 [NCBI] 8.86383e-06
CHRNB4 [NCBI] 8.86383e-06
TBX19 [NCBI] 8.86383e-06
PADI4 [NCBI] 8.86383e-06
COPA [NCBI] 8.86383e-06
IL22 [NCBI] 8.86383e-06
ADRA2C [NCBI] 8.86383e-06
HMCN1 [NCBI] 8.86383e-06
HSPA1L [NCBI] 8.86383e-06
CASP12 [NCBI] 8.86383e-06
MYO10 [NCBI] 8.86383e-06
FZD8 [NCBI] 8.86383e-06
NOD1 [NCBI] 8.86383e-06
PI7 [NCBI] 8.86383e-06
TIRAP [NCBI] 8.86383e-06
IMPA2 [NCBI] 8.86383e-06
KMO [NCBI] 8.86383e-06
PREP [NCBI] 8.86383e-06
GRM6 [NCBI] 8.86383e-06
HSCR1 [NCBI] 8.80029e-06
TCOF [NCBI] 8.69787e-06
HNFJ [NCBI] 8.63896e-06
TTR [NCBI] 8.62274e-06
SLC22A5 [NCBI] 8.60418e-06
NOS1 [NCBI] 8.60418e-06
LRP8 [NCBI] 8.60418e-06
REN [NCBI] 8.32164e-06
CNTF [NCBI] 8.32027e-06
GJA8 [NCBI] 8.2696e-06
KCNH2 [NCBI] 8.26709e-06
FMR1 [NCBI] 8.19532e-06
GAL [NCBI] 8.02874e-06
BRD2 [NCBI] 7.96598e-06
FBXO15 [NCBI] 7.96598e-06
IL13RA1 [NCBI] 7.96598e-06
ACOT7 [NCBI] 7.96598e-06
SGNE1 [NCBI] 7.96598e-06
NHLH1 [NCBI] 7.96598e-06
CCL7 [NCBI] 7.96598e-06
FBLN5 [NCBI] 7.96598e-06
WNT2 [NCBI] 7.96598e-06
PNOC [NCBI] 7.96598e-06
LST1 [NCBI] 7.96598e-06
PPP1R3A [NCBI] 7.96598e-06
FANCB [NCBI] 7.96598e-06
HLA-DPB1 [NCBI] 7.96598e-06
PALLD [NCBI] 7.96598e-06
XPNPEP2 [NCBI] 7.96598e-06
P2RY12 [NCBI] 7.96598e-06
LMNB2 [NCBI] 7.96598e-06
GPX2 [NCBI] 7.96598e-06
KCNA3 [NCBI] 7.96598e-06
FOXJ1 [NCBI] 7.96598e-06
COL17A1 [NCBI] 7.95023e-06
MKS1 [NCBI] 7.85938e-06
CDH1 [NCBI] 7.70871e-06
IGF1 [NCBI] 7.70871e-06
FMF [NCBI] 7.67354e-06
GSTP1 [NCBI] 7.64503e-06
PTX3 [NCBI] 7.64503e-06
NOS2A [NCBI] 7.64503e-06
HD [NCBI] 7.60461e-06
SCN3 [NCBI] 7.519e-06
hyperostosis corticalis generalisata [NCBI] 7.519e-06
HFE4 [NCBI] 7.519e-06
hepatitis b virus, susceptibility to [NCBI] 7.519e-06
keratitis-ichthyosis-deafness syndrome, autosomal dominant [NCBI] 7.519e-06
neuroblastoma [NCBI] 7.46973e-06
CD40LG [NCBI] 7.35308e-06
IRS2 [NCBI] 7.35308e-06
CST3 [NCBI] 7.35308e-06
STAT4 [NCBI] 7.35308e-06
ITGB3 [NCBI] 7.32478e-06
GPI [NCBI] 7.28725e-06
CJD [NCBI] 7.26773e-06
UCN3 [NCBI] 7.21151e-06
ROS1 [NCBI] 7.21151e-06
S100A7 [NCBI] 7.21151e-06
PROZ [NCBI] 7.21151e-06
GPR154 [NCBI] 7.21151e-06
COL9A3 [NCBI] 7.21151e-06
TLX3 [NCBI] 7.21151e-06
LOXL1 [NCBI] 7.21151e-06
GIPR [NCBI] 7.21151e-06
PODXL [NCBI] 7.21151e-06
INHBB [NCBI] 7.21151e-06
HMMR [NCBI] 7.21151e-06
HES1 [NCBI] 7.21151e-06
TAC1 [NCBI] 7.21151e-06
PSTPIP1 [NCBI] 7.21151e-06
VEGFB [NCBI] 7.21151e-06
GHRH [NCBI] 7.10773e-06
IL18 [NCBI] 7.07352e-06
CETP [NCBI] 7.07352e-06
SLS [NCBI] 7.04606e-06
TNFSF10 [NCBI] 6.98971e-06
IL4 [NCBI] 6.92831e-06
fabry disease [NCBI] 6.86601e-06
TG [NCBI] 6.80728e-06
MAOB [NCBI] 6.80561e-06
GRP [NCBI] 6.64898e-06
TGFB1 [NCBI] 6.61069e-06
GCKR [NCBI] 6.56424e-06
CCKBR [NCBI] 6.56424e-06
ST7 [NCBI] 6.56424e-06
GCLM [NCBI] 6.56424e-06
COL9A2 [NCBI] 6.56424e-06
CLC [NCBI] 6.56424e-06
AHI1 [NCBI] 6.56424e-06
RPL19 [NCBI] 6.56424e-06
SOD3 [NCBI] 6.56424e-06
NRG2 [NCBI] 6.56424e-06
MKKS [NCBI] 6.56424e-06
ABCA2 [NCBI] 6.56424e-06
hemojuvelin [NCBI] 6.56424e-06
PRG1 [NCBI] 6.56424e-06
MYLK [NCBI] 6.56424e-06
ETV1 [NCBI] 6.56424e-06
DNASE1 [NCBI] 6.56424e-06
FRZB [NCBI] 6.56424e-06
PCD [NCBI] 6.47982e-06
CCL17 [NCBI] 6.44259e-06
complement component 2 deficiency [NCBI] 6.30197e-06
myeloma, multiple [NCBI] 6.27938e-06
kawasaki disease [NCBI] 6.27938e-06
ehlers-danlos syndrome, type ii [NCBI] 6.27938e-06
SCA14 [NCBI] 6.27938e-06
DRRS [NCBI] 6.27938e-06
HFE [NCBI] 6.27744e-06
PF4 [NCBI] 6.19935e-06
APOD [NCBI] 6.11802e-06
PNMT [NCBI] 6.11704e-06
CVID [NCBI] 6.11545e-06
CYP2A6 [NCBI] 6.06502e-06
IL13 [NCBI] 6.06502e-06
TYK2 [NCBI] 6.00019e-06
BCL2L1 [NCBI] 6.00019e-06
FZD4 [NCBI] 6.00019e-06
CCL11 [NCBI] 6.00019e-06
PHYH [NCBI] 6.00019e-06
HAS1 [NCBI] 6.00019e-06
CTSG [NCBI] 6.00019e-06
CDH13 [NCBI] 6.00019e-06
MYCBP2 [NCBI] 6.00019e-06
MAP3K1 [NCBI] 6.00019e-06
CD [NCBI] 5.98612e-06
IHH [NCBI] 5.90187e-06
ABCC6 [NCBI] 5.83727e-06
LSA [NCBI] 5.75753e-06
CDK4 [NCBI] 5.70151e-06
H6PD [NCBI] 5.65866e-06
HEMB [NCBI] 5.63506e-06
ASPA [NCBI] 5.61823e-06
NEUROD1 [NCBI] 5.50262e-06
KERA [NCBI] 5.50262e-06
CXCL9 [NCBI] 5.50262e-06
RGS4 [NCBI] 5.50262e-06
TNFSF4 [NCBI] 5.50262e-06
PRND [NCBI] 5.50262e-06
GSS [NCBI] 5.50262e-06
SMAD7 [NCBI] 5.50262e-06
HOXA1 [NCBI] 5.50262e-06
NPPB [NCBI] 5.50262e-06
CCL5 [NCBI] 5.50262e-06
DAP3 [NCBI] 5.50262e-06
GATA2 [NCBI] 5.50262e-06
NRXN1 [NCBI] 5.50262e-06
TIMP2 [NCBI] 5.50262e-06
HTR1B [NCBI] 5.50262e-06
TRAF1 [NCBI] 5.50262e-06
SLOS [NCBI] 5.47657e-06
PTEN [NCBI] 5.4316e-06
PTPRC [NCBI] 5.40743e-06
ADRB2 [NCBI] 5.40743e-06
PDCD8 [NCBI] 5.27679e-06
CYP1A1 [NCBI] 5.27149e-06
MTC [NCBI] 5.22275e-06
HDC [NCBI] 5.22202e-06
SLC1A2 [NCBI] 5.20446e-06
AGTR1 [NCBI] 5.20446e-06
maple syrup urine disease [NCBI] 5.13573e-06
MHS1 [NCBI] 5.13573e-06
OCP [NCBI] 5.13573e-06
ABCG2 [NCBI] 5.10989e-06
SLC18A3 [NCBI] 5.10989e-06
ERCC8 [NCBI] 5.05937e-06
BRIP1 [NCBI] 5.05937e-06
LTK [NCBI] 5.05937e-06
CCND2 [NCBI] 5.05937e-06
JARID1C [NCBI] 5.05937e-06
DGAT1 [NCBI] 5.05937e-06
CILP [NCBI] 5.05937e-06
DKK1 [NCBI] 5.05937e-06
RARB [NCBI] 5.05937e-06
CX3CR1 [NCBI] 5.05937e-06
RPL3 [NCBI] 5.05937e-06
MS4A2 [NCBI] 5.05937e-06
MEIS1 [NCBI] 5.05937e-06
IL12RB1 [NCBI] 5.05937e-06
CCD [NCBI] 4.92478e-06
apc gene [NCBI] 4.91601e-06
ALB [NCBI] 4.91259e-06
hemophilia a [NCBI] 4.85178e-06
protoporphyria, erythropoietic [NCBI] 4.8205e-06
down syndrome [NCBI] 4.77701e-06
TSHR [NCBI] 4.70173e-06
SALL4 [NCBI] 4.66138e-06
F13B [NCBI] 4.66138e-06
ANXA2 [NCBI] 4.66138e-06
KRT8 [NCBI] 4.66138e-06
OLIG2 [NCBI] 4.66138e-06
CDC25A [NCBI] 4.66138e-06
LTA4H [NCBI] 4.66138e-06
ADD1 [NCBI] 4.66138e-06
PDCD5 [NCBI] 4.66138e-06
SELL [NCBI] 4.66138e-06
HDAC5 [NCBI] 4.66138e-06
TREX1 [NCBI] 4.66138e-06
ABCA4 [NCBI] 4.63881e-06
FCHL [NCBI] 4.61853e-06
ATM [NCBI] 4.59488e-06
TNFSF6 [NCBI] 4.58614e-06
COMP [NCBI] 4.48969e-06
SCN4A [NCBI] 4.46356e-06
TYMS [NCBI] 4.40878e-06
FGFR2 [NCBI] 4.4078e-06
LDLR [NCBI] 4.3266e-06
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency [NCBI] 4.31848e-06
XFS [NCBI] 4.31848e-06
FTNS [NCBI] 4.31848e-06
synovitis, granulomatous, with uveitis and cranial neuropathies [NCBI] 4.31848e-06
MED12 [NCBI] 4.30164e-06
TPH2 [NCBI] 4.30164e-06
GDF15 [NCBI] 4.30164e-06
MSR1 [NCBI] 4.30164e-06
OLR1 [NCBI] 4.30164e-06
alsin [NCBI] 4.30164e-06
MTP [NCBI] 4.30164e-06
TCF4 [NCBI] 4.30164e-06
EN2 [NCBI] 4.30164e-06
HLA-C [NCBI] 4.30164e-06
AQP7 [NCBI] 4.30164e-06
BLMH [NCBI] 4.30164e-06
CALCR [NCBI] 4.30164e-06
FCGR2A [NCBI] 4.30164e-06
CBP2 [NCBI] 4.30164e-06
ABCB4 [NCBI] 4.30164e-06
VWS [NCBI] 4.23549e-06
PTH [NCBI] 4.19529e-06
CASR [NCBI] 4.15878e-06
BCHE [NCBI] 4.14833e-06
CMT1B [NCBI] 4.08551e-06
CSA [NCBI] 4.08551e-06
osteogenesis imperfecta, type iia [NCBI] 4.08551e-06
NPS [NCBI] 4.08551e-06
SLC2A4 [NCBI] 4.03561e-06
AURKA [NCBI] 3.97468e-06
DSCR1 [NCBI] 3.97468e-06
CD14 [NCBI] 3.97468e-06
HIC1 [NCBI] 3.97468e-06
S100A8 [NCBI] 3.97468e-06
GGH [NCBI] 3.97468e-06
PRPH [NCBI] 3.97468e-06
AHCY [NCBI] 3.97468e-06
NOTCH3 [NCBI] 3.97468e-06
CACNA1F [NCBI] 3.97468e-06
SALL1 [NCBI] 3.97468e-06
APOC3 [NCBI] 3.97468e-06
SLC27A1 [NCBI] 3.97468e-06
HABP2 [NCBI] 3.97468e-06
ATRX [NCBI] 3.97367e-06
RELN [NCBI] 3.97367e-06
PGR [NCBI] 3.97158e-06
SDC2 [NCBI] 3.85811e-06
TNFRSF6 [NCBI] 3.82147e-06
EV [NCBI] 3.7881e-06
thyroid carcinoma, papillary [NCBI] 3.75349e-06
SCA6 [NCBI] 3.75349e-06
LWD [NCBI] 3.75349e-06
VASP [NCBI] 3.73179e-06
LIG4 [NCBI] 3.67613e-06
SOCS2 [NCBI] 3.67613e-06
EPAS1 [NCBI] 3.67613e-06
NTF3 [NCBI] 3.67613e-06
POU5F1 [NCBI] 3.67613e-06
TNFRSF25 [NCBI] 3.67613e-06
PLAU [NCBI] 3.67613e-06
SSTR5 [NCBI] 3.67613e-06
SLC26A3 [NCBI] 3.67613e-06
SPG4 [NCBI] 3.64688e-06
DNMT1 [NCBI] 3.56459e-06
MECP2 [NCBI] 3.55244e-06
AGS1 [NCBI] 3.54306e-06
ARVD1 [NCBI] 3.54306e-06
coenzyme q10 deficiency [NCBI] 3.54306e-06
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 3.54306e-06
LGMD1B [NCBI] 3.54306e-06
kaposi sarcoma [NCBI] 3.54306e-06
RET [NCBI] 3.52444e-06
HMBS [NCBI] 3.49316e-06
GC [NCBI] 3.43414e-06
sotos syndrome [NCBI] 3.43116e-06
aortic valve disease [NCBI] 3.43116e-06
PGF [NCBI] 3.40241e-06
PANK2 [NCBI] 3.40241e-06
MC3R [NCBI] 3.40241e-06
PLA2G2A [NCBI] 3.40241e-06
FLG [NCBI] 3.40241e-06
SELE [NCBI] 3.40241e-06
CYP2C9 [NCBI] 3.40241e-06
ATP1A2 [NCBI] 3.40241e-06
CYBA [NCBI] 3.40241e-06
CPS1 [NCBI] 3.40241e-06
PRTN3 [NCBI] 3.40241e-06
TPH1 [NCBI] 3.40241e-06
SLC19A1 [NCBI] 3.40241e-06
ADIPOR1 [NCBI] 3.40241e-06
FCGR3A [NCBI] 3.40241e-06
TLR2 [NCBI] 3.3823e-06
STAT1 [NCBI] 3.37538e-06
BGLAP [NCBI] 3.37538e-06
APOB [NCBI] 3.27891e-06
DAO [NCBI] 3.26234e-06
isoniazid inactivation [NCBI] 3.26234e-06
CLL [NCBI] 3.21751e-06
UCP1 [NCBI] 3.20073e-06
DBI [NCBI] 3.20073e-06
ANGPTL4 [NCBI] 3.1506e-06
MEF2A [NCBI] 3.1506e-06
USH2A [NCBI] 3.1506e-06
SLC16A2 [NCBI] 3.1506e-06
DLL3 [NCBI] 3.1506e-06
SCNN1A [NCBI] 3.1506e-06
IL17A [NCBI] 3.1506e-06
CSH1 [NCBI] 3.1506e-06
CYP11A1 [NCBI] 3.1506e-06
AMFR [NCBI] 3.1506e-06
FGB [NCBI] 3.1506e-06
SCN5A [NCBI] 3.13402e-06
GAPDH [NCBI] 3.12256e-06
spermatogenic failure, nonobstructive, y-linked [NCBI] 3.11897e-06
phenylketonuria [NCBI] 3.03688e-06
TBP [NCBI] 3.02858e-06
UCHL1 [NCBI] 2.91828e-06
ADSL [NCBI] 2.91828e-06
C5 [NCBI] 2.91828e-06
FOXC1 [NCBI] 2.91828e-06
BHMT [NCBI] 2.91828e-06
PAPPA [NCBI] 2.91828e-06
SQSTM1 [NCBI] 2.91828e-06
temporal arteritis [NCBI] 2.90191e-06
CTHM [NCBI] 2.87803e-06
gilbert syndrome [NCBI] 2.87803e-06
SCZD4 [NCBI] 2.87803e-06
glutaric acidemia i [NCBI] 2.87803e-06
mowat-wilson syndrome [NCBI] 2.87803e-06
HMS1 [NCBI] 2.87803e-06
PPARA [NCBI] 2.87245e-06
KDR [NCBI] 2.85903e-06
OPA1 [NCBI] 2.82285e-06
VMD [NCBI] 2.81737e-06
GJB2 [NCBI] 2.79846e-06
OMP [NCBI] 2.7475e-06
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of [NCBI] 2.70337e-06
FRAXE [NCBI] 2.70337e-06
MMP12 [NCBI] 2.70337e-06
CRHR1 [NCBI] 2.70337e-06
COL11A2 [NCBI] 2.70337e-06
PRKCG [NCBI] 2.70337e-06
HMOX1 [NCBI] 2.70337e-06
ECM1 [NCBI] 2.70337e-06
LBR [NCBI] 2.66159e-06
C3 [NCBI] 2.66159e-06
MB [NCBI] 2.62068e-06
PTGS2 [NCBI] 2.58293e-06
FGFR1 [NCBI] 2.58255e-06
DCC [NCBI] 2.55298e-06
GIP [NCBI] 2.52662e-06
MFS [NCBI] 2.50865e-06
SFTPB [NCBI] 2.50414e-06
CSF1 [NCBI] 2.50414e-06
KLF2 [NCBI] 2.50414e-06
ERCC6 [NCBI] 2.50414e-06
NNMT [NCBI] 2.50414e-06
CEACAM6 [NCBI] 2.50414e-06
nijmegen breakage syndrome [NCBI] 2.46096e-06
PTGS1 [NCBI] 2.31909e-06
CUBN [NCBI] 2.31909e-06
ABCC3 [NCBI] 2.31909e-06
GJB6 [NCBI] 2.31909e-06
CHRNA1 [NCBI] 2.31909e-06
DSP [NCBI] 2.31909e-06
CLN3 [NCBI] 2.31909e-06
CTSD [NCBI] 2.31909e-06
FLT3 [NCBI] 2.31909e-06
FLT1 [NCBI] 2.31909e-06
PEX7 [NCBI] 2.31909e-06
diabetes insipidus, neurohypophyseal type [NCBI] 2.30865e-06
TTP [NCBI] 2.30865e-06
IPEX [NCBI] 2.30865e-06
pseudoxanthoma elasticum, forme fruste [NCBI] 2.30865e-06
CTGF [NCBI] 2.29234e-06
ABCB1 [NCBI] 2.27373e-06
von willebrand disease [NCBI] 2.26153e-06
MITF [NCBI] 2.26153e-06
BMD [NCBI] 2.24805e-06
IGER [NCBI] 2.24805e-06
MMP9 [NCBI] 2.24793e-06
ESD [NCBI] 2.20924e-06
DLK1 [NCBI] 2.14694e-06
CYCS [NCBI] 2.14694e-06
ADAMTS13 [NCBI] 2.14694e-06
ASIP [NCBI] 2.14694e-06
F12 [NCBI] 2.14694e-06
MC2R [NCBI] 2.14694e-06
PDGFRB [NCBI] 2.14694e-06
GLC1A [NCBI] 2.13003e-06
SPINK1 [NCBI] 2.10575e-06
lynch syndrome i [NCBI] 2.10223e-06
ALK [NCBI] 2.07344e-06
XDH [NCBI] 2.04253e-06
PIGR [NCBI] 2.0026e-06
CTSB [NCBI] 1.98655e-06
GATA3 [NCBI] 1.98655e-06
WFS1 [NCBI] 1.98655e-06
NKX2-1 [NCBI] 1.98655e-06
LKS [NCBI] 1.98144e-06
CYP19A1 [NCBI] 1.9717e-06
LCN2 [NCBI] 1.9717e-06
TPMT [NCBI] 1.95332e-06
NPM1 [NCBI] 1.90328e-06
alopecia, androgenetic [NCBI] 1.90306e-06
diabetes mellitus, insulin-dependent, 2 [NCBI] 1.87302e-06
SVAS [NCBI] 1.84601e-06
UROS [NCBI] 1.83696e-06
HNF1B [NCBI] 1.83696e-06
PMM2 [NCBI] 1.83696e-06
MSX1 [NCBI] 1.83696e-06
IRF1 [NCBI] 1.83696e-06
CDH23 [NCBI] 1.83696e-06
MTND3 [NCBI] 1.83696e-06
ACOX1 [NCBI] 1.83696e-06
LHB [NCBI] 1.83696e-06
melanoma, uveal [NCBI] 1.82841e-06
MKKS [NCBI] 1.82294e-06
refsum disease [NCBI] 1.82294e-06
neural tube defects, folate-sensitive [NCBI] 1.82294e-06
EVR1 [NCBI] 1.82294e-06
longevity [NCBI] 1.82294e-06
SCCMS [NCBI] 1.82294e-06
SPCH1 [NCBI] 1.82294e-06
ELN [NCBI] 1.80224e-06
PAM [NCBI] 1.75558e-06
SST [NCBI] 1.7551e-06
LIPC [NCBI] 1.72166e-06
COL1A1 [NCBI] 1.70717e-06
RPS19 [NCBI] 1.69728e-06
AQP5 [NCBI] 1.69728e-06
FGFR4 [NCBI] 1.69728e-06
FSTL3 [NCBI] 1.69728e-06
SLC12A3 [NCBI] 1.69728e-06
DFFA [NCBI] 1.69728e-06
G6PD [NCBI] 1.67204e-06
GCCR [NCBI] 1.64372e-06
PLAUR [NCBI] 1.61163e-06
MTND2 [NCBI] 1.56677e-06
BMP15 [NCBI] 1.56677e-06
KLK7 [NCBI] 1.56677e-06
RBP1 [NCBI] 1.56451e-06
POAG [NCBI] 1.55459e-06
HYPP [NCBI] 1.48748e-06
PDS [NCBI] 1.48748e-06
IFNA1 [NCBI] 1.47163e-06
GJA5 [NCBI] 1.44474e-06
AHSG [NCBI] 1.44474e-06
OPA1 [NCBI] 1.44474e-06
PTPN1 [NCBI] 1.44474e-06
ATF6 [NCBI] 1.44474e-06
FPRL1 [NCBI] 1.44474e-06
MYD88 [NCBI] 1.44474e-06
MVK [NCBI] 1.44474e-06
HDAC1 [NCBI] 1.42588e-06
ANG [NCBI] 1.42507e-06
camurati-engelmann disease [NCBI] 1.41102e-06
factor xii deficiency [NCBI] 1.41102e-06
GABEB [NCBI] 1.41102e-06
FHM2 [NCBI] 1.41102e-06
AVSD [NCBI] 1.35567e-06
CHRNE [NCBI] 1.33059e-06
DYT1 [NCBI] 1.33059e-06
KL [NCBI] 1.33059e-06
SERPINA6 [NCBI] 1.32392e-06
ADM [NCBI] 1.31864e-06
COH1 [NCBI] 1.26153e-06
OCA1A [NCBI] 1.26153e-06
AFP [NCBI] 1.2336e-06
NR0B2 [NCBI] 1.22769e-06
FSHR [NCBI] 1.22769e-06
LOX [NCBI] 1.22769e-06
VCP [NCBI] 1.22769e-06
IPF1 [NCBI] 1.22376e-06
TIMP1 [NCBI] 1.22376e-06
TAF1 [NCBI] 1.22376e-06
CD2AP [NCBI] 1.22376e-06
TFF1 [NCBI] 1.22376e-06
HMGA2 [NCBI] 1.22376e-06
ARSB [NCBI] 1.22376e-06
IL3 [NCBI] 1.16633e-06
CFTR [NCBI] 1.13624e-06
INS [NCBI] 1.12396e-06
DISC1 [NCBI] 1.12378e-06
XPC [NCBI] 1.12378e-06
HDAC2 [NCBI] 1.12378e-06
ACP5 [NCBI] 1.09542e-06
SCD [NCBI] 1.07753e-06
PTN [NCBI] 1.07659e-06
brugada syndrome 1 [NCBI] 1.0647e-06
WFS1 [NCBI] 1.05063e-06
MLH1 [NCBI] 1.04989e-06
LMNA [NCBI] 1.03634e-06
HGFAC [NCBI] 1.0302e-06
GRIN1 [NCBI] 1.0302e-06
GPC3 [NCBI] 1.0302e-06
TGFBR2 [NCBI] 1.0302e-06
AQP3 [NCBI] 1.0302e-06
RTN4R [NCBI] 1.0302e-06
EDN3 [NCBI] 1.0302e-06
CAV3 [NCBI] 1.0302e-06
GH1 [NCBI] 9.95704e-07
PAEP [NCBI] 9.55634e-07
CDKN2A [NCBI] 9.50017e-07
MET [NCBI] 9.42622e-07
MEFV [NCBI] 9.42622e-07
IL1A [NCBI] 9.42622e-07
GCH1 [NCBI] 9.42622e-07
SLC40A1 [NCBI] 9.42622e-07
MTRNR1 [NCBI] 9.42622e-07
ABCB11 [NCBI] 9.16142e-07
KRT5 [NCBI] 8.6068e-07
PML [NCBI] 8.6068e-07
TERC [NCBI] 8.6068e-07
MN [NCBI] 8.6068e-07
oca2 gene [NCBI] 8.6068e-07
RECQL3 [NCBI] 8.6068e-07
SJS1 [NCBI] 8.55659e-07
MM [NCBI] 8.55659e-07
PCTT [NCBI] 8.55659e-07
SNCA [NCBI] 8.40714e-07
OPRM1 [NCBI] 8.0125e-07
HRG [NCBI] 7.93073e-07
SAA1 [NCBI] 7.84043e-07
canavan disease [NCBI] 7.77055e-07
PARK8 [NCBI] 7.77055e-07
AAA [NCBI] 7.77055e-07
polycythemia vera [NCBI] 7.77055e-07
ALS1 [NCBI] 7.64886e-07
FGF1 [NCBI] 7.64189e-07
homocystinuria [NCBI] 7.64189e-07
velocardiofacial syndrome [NCBI] 7.52392e-07
BSG [NCBI] 7.47202e-07
EPO [NCBI] 7.28284e-07
MEN1 [NCBI] 7.27767e-07
ABP1 [NCBI] 7.19452e-07
PPOX [NCBI] 7.12408e-07
FMO3 [NCBI] 7.12408e-07
CBD [NCBI] 7.12408e-07
DRPLA [NCBI] 6.92865e-07
CMD1A [NCBI] 6.77538e-07
GDF5 [NCBI] 6.45497e-07
PSIP1 [NCBI] 6.45497e-07
DAP [NCBI] 6.45497e-07
GHRL [NCBI] 6.45497e-07
CLU [NCBI] 6.19795e-07
PTHR1 [NCBI] 5.83055e-07
CTCF [NCBI] 5.83055e-07
MCP [NCBI] 5.61791e-07
DYT1 [NCBI] 5.56455e-07
TPO [NCBI] 5.45477e-07
LCT [NCBI] 5.42971e-07
EDMD2 [NCBI] 5.42213e-07
SCA17 [NCBI] 5.42213e-07
TERT [NCBI] 5.37071e-07
ESR2 [NCBI] 5.24846e-07
ALDH2 [NCBI] 5.24846e-07
ADRP [NCBI] 5.24846e-07
FN1 [NCBI] 5.24846e-07
SLC26A4 [NCBI] 5.24846e-07
UCP3 [NCBI] 5.06882e-07
DWS [NCBI] 4.96523e-07
PCD [NCBI] 4.96523e-07
PEMT [NCBI] 4.70653e-07
RS1 [NCBI] 4.70653e-07
PEDF [NCBI] 4.69359e-07
HLA-A [NCBI] 4.3918e-07
GBA [NCBI] 4.3918e-07
AQP1 [NCBI] 4.31108e-07
PDYN [NCBI] 4.20275e-07
NR0B1 [NCBI] 4.20275e-07
TNFRSF1A [NCBI] 4.07502e-07
PMP22 [NCBI] 4.0477e-07
BBS [NCBI] 3.84323e-07
human immunodeficiency virus type 1, susceptibility to [NCBI] 3.76038e-07
periodic fever, familial, autosomal dominant [NCBI] 3.76038e-07
cystinuria [NCBI] 3.76038e-07
DES [NCBI] 3.73527e-07
GNMT [NCBI] 3.73527e-07
SNRPN [NCBI] 3.73527e-07
UMOD [NCBI] 3.73527e-07
ATP7B [NCBI] 3.73527e-07
GRN [NCBI] 3.73527e-07
STAT6 [NCBI] 3.735e-07
pulmonary fibrosis, idiopathic [NCBI] 3.5514e-07
thrombocythemia, essential [NCBI] 3.5514e-07
PPH1 [NCBI] 3.5514e-07
DBA [NCBI] 3.49489e-07
SIRT1 [NCBI] 3.30235e-07
GAA [NCBI] 3.30235e-07
CSF2 [NCBI] 3.30235e-07
LIFR [NCBI] 3.30235e-07
TRPV1 [NCBI] 3.19227e-07
ARNT [NCBI] 3.19227e-07
IDUA [NCBI] 2.93392e-07
TFR2 [NCBI] 2.90239e-07
FOLH1 [NCBI] 2.90239e-07
HLA-DRA [NCBI] 2.90239e-07
STAT5A [NCBI] 2.73462e-07
BRAF [NCBI] 2.53389e-07
BMP2 [NCBI] 2.44433e-07
PARP1 [NCBI] 2.21355e-07
RYR1 [NCBI] 2.21355e-07
ENG [NCBI] 2.19544e-07
USF1 [NCBI] 2.19544e-07
BRRS [NCBI] 2.15044e-07
hodgkin lymphoma [NCBI] 2.1149e-07
MADA [NCBI] 2.1149e-07
FAAH [NCBI] 2.07549e-07
NF1 [NCBI] 2.02102e-07
XIST [NCBI] 1.99243e-07
GHR [NCBI] 1.9293e-07
BDNF [NCBI] 1.89867e-07
IL2RA [NCBI] 1.88575e-07
RUNX1 [NCBI] 1.88575e-07
C4A [NCBI] 1.88575e-07
PRNP [NCBI] 1.84845e-07
AIRE [NCBI] 1.82267e-07
PAX6 [NCBI] 1.78122e-07
VLDLR [NCBI] 1.60358e-07
SLC4A1 [NCBI] 1.58017e-07
SPS [NCBI] 1.47402e-07
ABCA1 [NCBI] 1.3478e-07
DMPK [NCBI] 1.3478e-07
ERBB2 [NCBI] 1.3478e-07
APCS [NCBI] 1.3478e-07
L1CAM [NCBI] 1.3478e-07
MAS [NCBI] 1.2543e-07
F2R [NCBI] 1.2097e-07
TLR5 [NCBI] 1.11732e-07
DDC [NCBI] 1.08262e-07
SCDO1 [NCBI] 1.07485e-07
HOKPP [NCBI] 1.07485e-07
alcohol dependence [NCBI] 1.07485e-07
osteoporosis [NCBI] 1.07485e-07
TNC [NCBI] 9.64124e-08
COL3A1 [NCBI] 9.11133e-08
FGF23 [NCBI] 9.11133e-08
AQP2 [NCBI] 8.83317e-08
JAK2 [NCBI] 8.52926e-08
alzheimer disease 3 [NCBI] 7.91107e-08
leiomyomatosis and renal cell cancer, hereditary [NCBI] 7.91107e-08
THPO [NCBI] 7.3743e-08
TFF3 [NCBI] 7.3743e-08
DSPP [NCBI] 7.3743e-08
CCL2 [NCBI] 7.3743e-08
REG3A [NCBI] 7.3743e-08
MTAP [NCBI] 7.28285e-08
factor vii deficiency [NCBI] 7.28285e-08
CEACAM5 [NCBI] 6.20986e-08
protein c deficiency, congenital thrombotic disease due to [NCBI] 6.03518e-08
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 5.84735e-08
DSG3 [NCBI] 5.6788e-08
SH2D1A [NCBI] 5.6788e-08
GPT [NCBI] 4.8193e-08
RIPK1 [NCBI] 4.2907e-08
MTND1 [NCBI] 4.2907e-08
FH [NCBI] 4.2907e-08
MHA [NCBI] 3.98178e-08
SEDC [NCBI] 3.98178e-08
central core disease of muscle [NCBI] 3.98178e-08
SCA7 [NCBI] 3.73904e-08
SOCS3 [NCBI] 3.73027e-08
CD36 [NCBI] 3.73027e-08
BIRC1 [NCBI] 2.77188e-08
SPARC [NCBI] 2.77188e-08
PPSH [NCBI] 2.73909e-08
SPDA1 [NCBI] 2.73909e-08
POF1 [NCBI] 2.73909e-08
musical perfect pitch [NCBI] 2.73909e-08
PCI [NCBI] 2.68919e-08
PI [NCBI] 2.35718e-08
UGT1A1 [NCBI] 1.94808e-08
IRS1 [NCBI] 1.94808e-08
MSH2 [NCBI] 1.34427e-08
SLC18A2 [NCBI] 1.34427e-08
KIT [NCBI] 1.34427e-08
INSL3 [NCBI] 1.34427e-08
AKR1B1 [NCBI] 1.3077e-08
MMP2 [NCBI] 1.26303e-08
dystrophia myotonica 1 [NCBI] 8.15012e-09
PYY [NCBI] 7.63666e-09
PARG [NCBI] 7.44204e-09
cortisol 11-beta-ketoreductase deficiency [NCBI] 7.21044e-09
DYX1 [NCBI] 5.58055e-09
ALMS [NCBI] 5.58055e-09
hepatocellular carcinoma [NCBI] 5.58055e-09
KRAS [NCBI] 3.26674e-09
AQP4 [NCBI] 3.26674e-09
HRAS [NCBI] 3.26674e-09
KLF4 [NCBI] 3.24163e-09
GNRHR [NCBI] 3.24163e-09
DFFB [NCBI] 3.24163e-09
DFNB1 [NCBI] 2.20043e-09
FHM1 [NCBI] 2.20043e-09
UCP2 [NCBI] 1.69401e-09
ENPEP [NCBI] 8.46791e-10
KCNQ1 [NCBI] 8.46791e-10
TF [NCBI] 8.45101e-10
IGF2 [NCBI] 7.80452e-10
BMP4 [NCBI] 3.67791e-10
TLR9 [NCBI] 3.67791e-10
UCN [NCBI] 1.09155e-12



Database Center for Life Science